Innovation in the development of nanomedicines
CARLINA Technologies is a biopharmaceutical company specialized in the development of nanomedicines utilizing innovative non-denaturing drug delivery technologies for therapeutic proteins, peptides and other types of drugs.
The company develops controlled-release pharmaceutical versions of drugs capable of targeting them to their site of action. This results in increased efficacy and safety of treatments leading to improved patients’ compliance and quality of life.
Terms of collaboration
☐ Research collaboration
☒ Service provision
☒ Material supply